基于PCR循环阈值双重报告预测毒素结果可减少毒素阴性患者治疗且不增加不良结局
该研究评估了基于PCR循环阈值(CT)预测毒素结果的双重报告对艰难梭菌感染(CDI)临床结局的影响。对430例PCR阳性成人患者回顾分析发现,CT-毒素阳性患者90天内毒素阳转率更高(17.4% vs 8.0%,P=0.003),且所有暴发性CDI均为CT-毒素阳性;CT-毒素阴性患者中51.5%接受治疗,但治疗与未治疗者的阳转率和30天全因死亡率无显著差异。
要点
- CT-毒素阳性患者90天内毒素阳转率显著高于阴性患者(17.4% vs 8.0%,P=0.003)。
- 所有暴发性CDI病例(n=21)均为CT-毒素阳性结果。
- CT-毒素阴性患者中51.5%接受CDI治疗,治疗与未治疗者结局无显著差异。
核心结论
- 基于PCR CT值的毒素预测可识别CDI相关并发症高风险患者,并减少CT-毒素阴性患者的治疗。
研究设计与样本
- 回顾性队列研究,纳入2016年10月至2017年10月GeneXpert PCR阳性成人患者,共482次阳性检测对应430例独特患者。
主要发现
- CT-毒素阳性患者282例,阴性200例;阳性患者白细胞计数更高(12.5×10^3 vs 9.3×10^3 cells/μl,P=0.001)。
- CT-毒素阳性患者90天内毒素阳转率显著高于阴性患者(17.4% [n=49] vs 8.0% [n=16],P=0.003)。
- 30天全因死亡率在CT-毒素阴性患者中更高(11.1% vs 6.8%,P=0.1),但阴性患者中无死亡直接归因于CDI。
- CT-毒素阴性患者中51.5%(n=103)接受CDI治疗;治疗与未治疗者的阳转率(8.8% vs 7.2%,P=0.8)和全因死亡率(8.8% vs 13.4%,P=0.3)无显著差异。
关键数值与推荐
- 所有暴发性CDI病例(n=21)均为CT-毒素阳性结果。
临床怎么用
- 利用PCR CT值预测毒素结果进行双重报告,可辅助识别CDI并发症高风险患者并减少对CT-毒素阴性患者的治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nucleic acid amplification tests are commonly used to diagnose Clostridioides difficile infection (CDI). Two-step testing with a toxin enzyme immunoassay is recommended to discriminate between infection and colonization but requires additional resources. Prior studies showed that PCR cycle threshold (CT ) can predict toxin positivity with high negative predictive value. Starting in October 2016, the predicted toxin result (CT-toxin) based on a validated cutoff was routinely reported at our facility. To evaluate the clinical efficacy of this reporting, all adult patients with positive GeneXpert PCR results from October 2016 through October 2017 underwent a chart review to measure the recurrence of or conversion to a CT-toxin+ result and 30-day all-cause mortality. There were 482 positive PCR tests in 430 unique patients, 282 CT-toxin+ and 200 CT-toxin- Patient characteristics were similar at testing, though CT-toxin+ patients had higher white blood cell (WBC) counts (12.5 × 103 versus 9.3 × 103 cells/μl; P = 0.001). All cases (n = 21) of fulminant CDI had a CT-toxin+ result. Index CT-toxin+ patients were significantly more likely to have a CT-toxin+ result within 90 days than CT-toxin- patients (17.4% [n = 49] versus 8.0% [n = 16], respectively; P = 0.003). Thirty-day all-cause mortality was higher in CT-toxin- patients (11.1% versus 6.8%; P = 0.1), though no deaths in CT-toxin- patients were directly attributable to CDI. Of the 200 CT-toxin- patients, 51.5% (n = 103) were treated for CDI. The rates of conversion to a CT-toxin+ result (8.8% versus 7.2%; P = 0.8) and all-cause mortality (8.8% versus 13.4%; P = 0.3) were similar between treated and untreated CT-toxin- patients, respectively. CT -based toxin prediction may identify patients at higher risk for CDI-related complications and reduce treatment among CT-toxin- patients.
引用
- Hitchcock MM, Holubar M, Hogan CA, et al. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes. J Clin Microbiol. 2019. PMID: 31511334. doi:10.1128/JCM.01288-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。